Recent Trends in Drug Design and Discovery

Area of Science:

• Computational Chemistry
• Pharmacology
• Bioinformatics

Background:

• Structure-based drug design (SBDD) identifies selective inhibitors using 3D target structures.
• Key challenges include assessing drug-likeness, target druggability, specificity, and off-target binding.
• Computational methods are crucial for addressing these challenges in drug discovery.

Purpose of the Study:

• To advance drug design strategies for novel inhibitors against specific disease-related target proteins.
• To explore the application of statistical machine learning in analyzing structural and chemical data for drug design.
• To improve the efficacy and safety of new chemical inhibitors.

Main Methods:

• Review of computational algorithms and analytical methods for biological data analysis.
• Application of molecular modeling techniques (e.g., semi-empirical force fields, quantum mechanics) for small datasets.
• Utilization of statistics-based methods like machine learning (ML) and Quantitative Structure-Activity Relationship (QSAR) for large-scale data analysis.

Main Results:

• A comprehensive review of new drug lead development strategies for specific targets.
• Demonstration of integrated approaches combining different computational methods.
• Plausible outcomes highlighting the effectiveness of advanced analytical techniques.

Conclusions:

• Recent advancements in SBDD leverage molecular modeling, ML, and data analytics.
• These integrated approaches enhance the development of novel inhibitors.
• Natural products in drug discovery are also considered within this framework.